Literature DB >> 7002399

The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes.

R A Newman, M G Ormerod, M F Greaves.   

Abstract

HLA-DR antigens have been demonstrated on the secretory epithelia of lactating breast using rabbit anti-p28,33 ('Ia-like') and mouse monoclonal anti-HLA-DR 'framework'. Normal non-lactating breast, benign or malignant tumours, epithelial cells from normal breast or isolated from milk and a presumptive breast carcinoma cell line (MCF-7) were all HLA-DR-negative. HLA-DR, HLA (ABC 'framework') and beta 2-microglobulin determinants were also demonstrated on the surface of milk fat globules (MFG) which were unreactive with monoclonal antibodies to thymus cells or leucocytes. A monoclonal antibody detecting allelic HLA-DR determinants (HLA-DRw 1,2,6) was positive on 40% of MFG samples tested, positive reactions being concordant, when tested, with blood B lymphocytes. Antisera raised against MFG membranes also contain anti-HLA-DR activity. Whether the breast epithelial cells synthesize HLA-DR molecules or acquire these passively from mononuclear cells which infiltrate during lactation is not yet resolved.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002399      PMCID: PMC1537033     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Products of the major histocompatibility complex and their relationship to the immune response.

Authors:  A Munro; S Bright
Journal:  Nature       Date:  1976-11-11       Impact factor: 49.962

Review 2.  Functional specificity of thymus- dependent lymphocytes.

Authors:  W E Paul; B Benacerraf
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

3.  Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule.

Authors:  R L Ceriani; K Thompson; J A Peterson; S Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen.

Authors:  S von Kleist; G Chavanel; P Burtin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

Review 6.  Genetic and functional analysis of the Ia antigens: their possible role in regulating the immune response.

Authors:  H O McDevitt; T L Delovitch; J L Press; D B Murphy
Journal:  Transplant Rev       Date:  1976

7.  Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.

Authors:  U Schneider; H U Schwenk; G Bornkamm
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

8.  Preparation of antisera specific for human B cells by immunization of rabbits with immune complexes.

Authors:  K I Welsh; M J Turner
Journal:  Tissue Antigens       Date:  1976-09

9.  Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis.

Authors:  M McWilliams; J M Phillips-Quagliata; M E Lamm
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

10.  Biochemical and morphological comparison of plasma membrane and milk fat globule membrane from bovine mammary gland.

Authors:  T W Keenan; D J Morré; D E Olson; W N Yunghans; S Patton
Journal:  J Cell Biol       Date:  1970-01       Impact factor: 10.539

View more
  12 in total

1.  Luteinization of human granulosa cells in vivo is associated with expression of MHC class II antigens.

Authors:  E L Khoury; L A Marshall
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

Review 2.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

3.  Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.

Authors:  P Möller; T Mattfeldt; C Gross; P Schlosshauer; A Koch; K Koretz; G Moldenhauer; M Kaufmann; H F Otto
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Presence of HLA-D/DR antigens on the membrane of breast tumour cells.

Authors:  D Bernard; J C Maurizis; F Rusé; J Chassagne; P Chollet; B Sauvezie; M de Latour; R Plagne
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes.

Authors:  J Fischer; P J Klein; G H Farrar; F G Hanisch; G Uhlenbruck
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

Review 6.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

Authors:  P A Edwards
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

7.  Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines.

Authors:  D J Bernard; F Courjal; J C Maurizis; Y J Bignon; P Chollet; R Plagne
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

8.  Ia antigens in rat kidney, with special reference to their expression in tubular epithelium.

Authors:  G Mayrhofer; M A Schon-Hegrad
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.

Authors:  J Bártek; M Petrek; B Vojtĕsek; J Bártková; J Kovarík; A Rejthar
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

10.  Secretory IgA: Designed for Anti-Microbial Defense.

Authors:  Per Brandtzaeg
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.